Information Provided By: 
Fly News Breaks for May 2, 2019
AYX
May 2, 2019 | 09:14 EDT
Needham analyst Jack Andrews raised his price target on Alteryx to $108 and kept his Buy rating after its "strong" Q1 results and raised FY19 guidance. The analyst cites the the company's increasing focus on enterprise customers driving large initial land deals and strong customer additions, also noting that the company's self-service tools serve a "pivotal function in the Big Data software stack."
News For AYX From the Last 2 Days
AYX
Apr 23, 2024 | 08:31 EDT
New option listings for April 23rd include Express Inc (EXPRQ). Option delistings effective April 23rd include PGT Innovations Inc (PGTI), NGM Biopharmaceuticals Inc (NGM), Karuna Therapeutics Inc (KRTX), KINNATE BIOPHARMA INC (KNTE), Daseke Inc (DSKE), Tritium Dcfc Ltd (DCFC), Xtrackers MSCI All China Equity ETF (CN), CymaBay Therapeutics Inc (CBAY), Alteryx Inc (AYX), XTRACKERS MSCI CHINA A INCLUSION EQUITY ETF (ASHX), Recro Pharma, Inc. (SCTL), Splunk Inc (SPLK), and Textainer Group Holdings Limited (TGH).
